2. Repository of UKIM

Repository of UKIM


Zdraveska, Marija

Network Lab View Statistics Email Alert RSS Feed

Profile

Full Name
Zdraveska, Marija
Vernacular Name
Zdraveska M.
 
Variants
Zdraveska M
M. Zdraveska
Marija Zdraveska
Lazarevska Marija
Lazarevska M
Здравеска Марија
Здравеска М
Лазаревска Марија
Лазаревска М
Marija Zdravevska
 
Main Affiliation
 
Loading... 2 0 5 0 false
Loading... 3 0 5 0 false

Publications

Refined By:
Author:  Monreal M

Results 1-18 of 18 (Search time: 0.013 seconds).

PreviewTitleAuthor(s)Issue DateType
1Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous ThromboembolismRuiz-Artacho P,; Trujillo-Santos J,; López-Jiménez L,; Font C,; Díaz-Pedroche MDC,; Sánchez Muñoz-Torrero JF,; Peris ML,; Skride A,; Maestre A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2018Article
2The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.Mahé I; Chidiac J; Bertoletti L; Font C; Trujillo-Santos J; Peris M; Pérez Ductor C; Nieto S; Grandone E; Monreal M; RIETE investigators; Bosevski M ; Zdraveska M 2016Article
3Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.Moustafa F; Giorgi Pierfranceschi M; Di Micco P; Bucherini E; Lorenzo A; Villalobos A; Nieto JA; Valero B; Sampériz ÁL; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
4Clinical Presentation and Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis.Galanaud JP; Trujillo-Santos J,; Bikdeli B; Bertoletti L,; Di Micco P; Poénou G,; Falgá C; Zdraveska M; Lima J,; Rivera-Civico F; Muixi JF; Monreal M; RIETE Investigators.; Zdraveska M 2023Article
5Development of a Risk Prediction Score for Occult Cancer in Patients With VTEJara-Palomares L,; Otero R,; Jimenez D,; Carrier M,; Tzoran I,; Brenner B,; Margeli M,; Praena-Fernandez JM,; Grandone E,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
6Fondaparinux in the initial and long-term treatment of venous thromboembolismPesavento R; Amitrano M; Trujillo-Santos J; Di Micco P; Mangiacapra S; López-Jiménez L; Piovella C; Prandoni P; Monreal M; RIETE Investigators.; Bosevski M ; Zdraveska M 2015Article
7Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registryAlatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators; Bosevski M ; Zdraveska M 2017Article
8Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
9Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators; Bosevski M ; Zdraveska M 2017Article
10Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
11Predictors of active cancer thromboembolic outcomes. RIETE experience of the Khorana score in cancer-associated thrombosis.Tafur AJ,; Caprini JA,; Cote L; Trujillo-Santos J; Del Toro J,; Garcia-Bragado F; Tolosa C,; Barillari G,; Visona A,; Monreal M; RIETE Investigators; Bosevski, M ; Zdraveska M 2017Article
12Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimensTrujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
13Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE RegistryBarillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
14Systolic blood pressure and mortality in acute symptomatic pulmonary embolismQuezada A,; Jiménez D,; Bikdeli B,; Moores L,; Porres-Aguilar M,; Aramberri M,; Lima J,; Ballaz A,; Yusen RD, Monreal M; RIETE investigators.; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2020Article
15Uterine bleeding during anticoagulation in women with venous thromboembolism.Moustafa F,; Fernández S,; Fernández-Capitán C,; Nieto JA,; Pedrajas JM,; Visoná A,; Valero B,; Marchena PJ,; Braester A,; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2017Article
16Venous thromboembolism in centenarians: Findings from the RIETE registryLacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M; RIETE Investigators; Bosevski M ; Zdraveska M 2016Article
17Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registryPortillo J; de la Rocha VI; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M; RIETE Investigations; Bosevski M ; Zdraveska M 2015Article
18Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous ThromboembolismChai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Marija Zdraveska ; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M; RIETE investigatorsApr-2018Article